Skip to Content

Glass House Brands Inc Ordinary Shares - Class A GLASF

Morningstar Rating
$9.61 +0.26 (2.78%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GLASF is trading within a range we consider fairly valued.
Price
$9.59
Fair Value
$82.73
Uncertainty
Very High
1-Star Price
$49.23
5-Star Price
$6.16
Economic Moat
Htwp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GLASF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$9.35
Day Range
$9.349.61
52-Week Range
$2.8810.50
Bid/Ask
$9.59 / $9.61
Market Cap
$683.13 Mil
Volume/Avg
110,442 / 117,543

Key Statistics

Price/Earnings (Normalized)
Price/Sales
4.30
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. it has three reportable segments retail, wholesale biomass, and cannabis-related consumer packaged goods. It generates the majority of its revenue from wholesale biomass.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
413

Comparables

Valuation

Metric
GLASF
CURA
TRUL
Price/Earnings (Normalized)
75.11
Price/Book Value
7.604.051.69
Price/Sales
4.303.072.11
Price/Cash Flow
73.9172.3085.73
Price/Earnings
GLASF
CURA
TRUL

Financial Strength

Metric
GLASF
CURA
TRUL
Quick Ratio
0.380.311.87
Current Ratio
0.560.854.16
Interest Coverage
−7.98−0.24−2.56
Quick Ratio
GLASF
CURA
TRUL

Profitability

Metric
GLASF
CURA
TRUL
Return on Assets (Normalized)
−7.03%−3.72%−3.80%
Return on Equity (Normalized)
−18.64%−10.45%−7.03%
Return on Invested Capital (Normalized)
−6.32%−2.20%−2.14%
Return on Assets
GLASF
CURA
TRUL
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ANwznmszkSrxs$76.2 Bil
MKKGY
Merck KGaA ADRLxdcvktchMnwbx$70.9 Bil
HLN
Haleon PLC ADRJzcyzxtmStfy$37.8 Bil
VTRS
Viatris IncFycqqhxksDpn$14.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRFqwlymspCmz$12.7 Bil
CTLT
Catalent IncDkwgvnlMmthrd$10.2 Bil
PRGO
Perrigo Co PLCXqssjrjJxvn$4.4 Bil
CURLF
Curaleaf Holdings IncRsvfxhmFwjwd$4.1 Bil
PBH
Prestige Consumer Healthcare IncPdxwzyjkPzpwvf$3.5 Bil
GTBIF
Green Thumb Industries IncYzslwlbnqfZpqn$3.1 Bil

Sponsor Center